Cite
HARVARD Citation
Terhorst‐Molawi, D. et al. (2023). Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy. 78 (5), pp. 1269-1279. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Terhorst‐Molawi, D. et al. (2023). Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy. 78 (5), pp. 1269-1279. [Online].